Ono Pharmaceutical Co Ltd
TSE:4528
Ono Pharmaceutical Co Ltd
TSE:4528
Price:
1 809
JPY
-1.5%
Market Closed
Market Cap:
849.6B
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Ono Pharmaceutical Co Ltd
1809
-27.5 (-1.5%)
| 52 Week Range |
1 809
2 849
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Ono Pharmaceutical Co Ltd
Income Statement
Earnings Waterfall
Ono Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
|
Revenue
|
500.3B
JPY
|
|
Cost of Revenue
|
-126.6B
JPY
|
|
Gross Profit
|
373.7B
JPY
|
|
Operating Expenses
|
-224.4B
JPY
|
|
Operating Income
|
149.3B
JPY
|
|
Other Expenses
|
-28.3B
JPY
|
|
Net Income
|
121B
JPY
|
Income Statement
Ono Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
Currency: JPY
| Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
137 756
N/A
|
134 888
-2%
|
139 090
+3%
|
135 775
-2%
|
139 663
+3%
|
143 698
+3%
|
140 928
-2%
|
160 284
+14%
|
183 346
+14%
|
207 707
+13%
|
236 710
+14%
|
244 797
+3%
|
246 953
+1%
|
248 517
+1%
|
256 523
+3%
|
261 836
+2%
|
272 166
+4%
|
284 787
+5%
|
284 464
0%
|
288 634
+1%
|
291 375
+1%
|
293 247
+1%
|
290 736
-1%
|
292 420
+1%
|
293 351
+0%
|
293 886
+0%
|
302 054
+3%
|
309 284
+2%
|
321 734
+4%
|
332 887
+3%
|
345 781
+4%
|
361 361
+5%
|
380 720
+5%
|
403 985
+6%
|
428 951
+6%
|
447 187
+4%
|
460 481
+3%
|
489 199
+6%
|
498 071
+2%
|
502 672
+1%
|
500 332
0%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(33 216)
|
(33 988)
|
(34 362)
|
(35 136)
|
(36 062)
|
(36 996)
|
(38 363)
|
(41 524)
|
(48 498)
|
(55 196)
|
(61 811)
|
(65 524)
|
(64 462)
|
(63 788)
|
(65 491)
|
(65 391)
|
(70 396)
|
(76 528)
|
(81 748)
|
(83 829)
|
(84 414)
|
(83 869)
|
(78 792)
|
(79 063)
|
(78 896)
|
(79 155)
|
(83 659)
|
(85 573)
|
(87 809)
|
(89 380)
|
(90 056)
|
(93 511)
|
(97 649)
|
(101 656)
|
(106 664)
|
(110 062)
|
(113 296)
|
(121 115)
|
(121 737)
|
(127 126)
|
(126 626)
|
|
| Gross Profit |
104 540
N/A
|
100 900
-3%
|
104 728
+4%
|
100 639
-4%
|
103 601
+3%
|
106 702
+3%
|
102 565
-4%
|
118 760
+16%
|
134 848
+14%
|
152 511
+13%
|
174 899
+15%
|
179 273
+3%
|
182 491
+2%
|
184 729
+1%
|
191 032
+3%
|
196 445
+3%
|
201 770
+3%
|
208 259
+3%
|
202 716
-3%
|
204 805
+1%
|
206 961
+1%
|
209 378
+1%
|
211 944
+1%
|
213 357
+1%
|
214 455
+1%
|
214 731
+0%
|
218 395
+2%
|
223 711
+2%
|
233 925
+5%
|
243 507
+4%
|
255 725
+5%
|
267 850
+5%
|
283 071
+6%
|
302 329
+7%
|
322 287
+7%
|
337 125
+5%
|
347 185
+3%
|
368 084
+6%
|
376 334
+2%
|
375 546
0%
|
373 706
0%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(85 454)
|
(86 486)
|
(87 415)
|
(85 845)
|
(79 910)
|
(80 530)
|
(81 920)
|
(88 370)
|
(98 770)
|
(106 272)
|
(113 413)
|
(103 170)
|
(113 176)
|
(115 792)
|
(119 860)
|
(138 495)
|
(137 381)
|
(139 212)
|
(142 077)
|
(141 496)
|
(142 951)
|
(140 642)
|
(136 036)
|
(135 905)
|
(129 902)
|
(126 717)
|
(124 760)
|
(125 226)
|
(132 846)
|
(139 407)
|
(157 417)
|
(157 286)
|
(171 506)
|
(177 035)
|
(178 669)
|
(187 365)
|
(202 036)
|
(209 355)
|
(212 335)
|
(215 498)
|
(224 429)
|
|
| Selling, General & Administrative |
(40 762)
|
(41 726)
|
(42 877)
|
(40 824)
|
(37 642)
|
(38 512)
|
(40 104)
|
(42 628)
|
(51 202)
|
(55 053)
|
(58 748)
|
(60 660)
|
(64 236)
|
(65 356)
|
(66 368)
|
(66 353)
|
(68 841)
|
(69 670)
|
(70 745)
|
(68 000)
|
(69 581)
|
(69 561)
|
(68 803)
|
(65 196)
|
(65 304)
|
(63 762)
|
(64 958)
|
(66 616)
|
(73 987)
|
(77 069)
|
(78 502)
|
(74 119)
|
(79 828)
|
(82 346)
|
(85 716)
|
(86 643)
|
(91 243)
|
(94 145)
|
(96 634)
|
(96 930)
|
(104 673)
|
|
| Research & Development |
(43 505)
|
(42 592)
|
(41 946)
|
(41 346)
|
(39 972)
|
(40 789)
|
(40 750)
|
0
|
(46 652)
|
(49 595)
|
(52 949)
|
(57 506)
|
(61 325)
|
(63 599)
|
(66 892)
|
(68 821)
|
(69 593)
|
(70 453)
|
(71 628)
|
(70 008)
|
(70 265)
|
(67 896)
|
(64 207)
|
(66 497)
|
(62 874)
|
(61 295)
|
0
|
(62 384)
|
(47 172)
|
(51 089)
|
(68 001)
|
(75 879)
|
(80 047)
|
(82 956)
|
(92 390)
|
(95 344)
|
(100 511)
|
(105 076)
|
(105 862)
|
(112 174)
|
(116 451)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(1 398)
|
0
|
0
|
0
|
(1 351)
|
0
|
0
|
0
|
(1 389)
|
0
|
0
|
0
|
(1 702)
|
0
|
0
|
0
|
(2 033)
|
0
|
0
|
0
|
(2 483)
|
0
|
0
|
0
|
(2 614)
|
0
|
0
|
0
|
(2 938)
|
0
|
0
|
0
|
(2 843)
|
0
|
0
|
0
|
(2 881)
|
0
|
|
| Other Operating Expenses |
(1 187)
|
(2 168)
|
(2 592)
|
(2 277)
|
(2 296)
|
(1 229)
|
(1 066)
|
(44 391)
|
(916)
|
(1 624)
|
(1 716)
|
16 385
|
12 385
|
13 163
|
13 400
|
(1 619)
|
1 053
|
911
|
296
|
(1 455)
|
(3 105)
|
(3 185)
|
(3 026)
|
(1 729)
|
(1 724)
|
(1 660)
|
(59 802)
|
6 388
|
(11 687)
|
(11 249)
|
(10 914)
|
(4 350)
|
(11 631)
|
(11 733)
|
(563)
|
(2 535)
|
(10 282)
|
(10 134)
|
(9 839)
|
(3 513)
|
(3 305)
|
|
| Operating Income |
19 086
N/A
|
14 414
-24%
|
17 313
+20%
|
14 794
-15%
|
23 691
+60%
|
26 172
+10%
|
20 645
-21%
|
30 390
+47%
|
36 078
+19%
|
46 239
+28%
|
61 486
+33%
|
76 103
+24%
|
69 315
-9%
|
68 937
-1%
|
71 172
+3%
|
57 950
-19%
|
64 389
+11%
|
69 047
+7%
|
60 639
-12%
|
63 309
+4%
|
64 010
+1%
|
68 736
+7%
|
75 908
+10%
|
77 452
+2%
|
84 553
+9%
|
88 014
+4%
|
93 635
+6%
|
98 485
+5%
|
101 079
+3%
|
104 100
+3%
|
98 308
-6%
|
110 564
+12%
|
111 565
+1%
|
125 294
+12%
|
143 618
+15%
|
149 760
+4%
|
145 149
-3%
|
158 729
+9%
|
163 999
+3%
|
160 048
-2%
|
149 277
-7%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
2 861
|
3 098
|
3 233
|
3 511
|
3 864
|
3 342
|
2 976
|
2 779
|
2 233
|
2 256
|
2 866
|
2 278
|
2 775
|
2 869
|
2 509
|
3 252
|
3 165
|
3 399
|
3 184
|
3 152
|
2 895
|
2 525
|
2 681
|
2 232
|
2 248
|
2 310
|
2 028
|
2 374
|
2 311
|
2 348
|
2 275
|
1 487
|
1 698
|
1 520
|
1 438
|
1 563
|
1 724
|
3 085
|
2 450
|
3 740
|
5 389
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
117
|
0
|
0
|
0
|
(3 819)
|
0
|
0
|
0
|
2 734
|
0
|
0
|
0
|
(1 299)
|
0
|
0
|
0
|
39
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(7 124)
|
0
|
0
|
0
|
(7 797)
|
0
|
0
|
0
|
(113)
|
0
|
|
| Total Other Income |
(1)
|
0
|
2
|
0
|
0
|
(2)
|
(3)
|
(14)
|
(2)
|
0
|
1
|
(22)
|
1
|
0
|
(2)
|
(14)
|
(1)
|
(1)
|
0
|
(21)
|
4
|
5
|
5
|
(27)
|
6
|
4
|
4
|
41
|
(3)
|
0
|
(3)
|
98
|
(2)
|
(1)
|
(1)
|
6
|
(4)
|
(5)
|
(4)
|
59
|
0
|
|
| Pre-Tax Income |
21 946
N/A
|
17 512
-20%
|
20 548
+17%
|
18 305
-11%
|
27 555
+51%
|
29 512
+7%
|
23 618
-20%
|
33 272
+41%
|
38 309
+15%
|
48 495
+27%
|
64 353
+33%
|
74 540
+16%
|
72 091
-3%
|
71 806
0%
|
73 679
+3%
|
63 922
-13%
|
67 553
+6%
|
72 445
+7%
|
63 823
-12%
|
65 141
+2%
|
66 909
+3%
|
71 266
+7%
|
78 594
+10%
|
79 696
+1%
|
86 807
+9%
|
90 328
+4%
|
95 667
+6%
|
100 890
+5%
|
103 387
+2%
|
106 446
+3%
|
100 580
-6%
|
105 025
+4%
|
113 261
+8%
|
126 813
+12%
|
145 055
+14%
|
143 532
-1%
|
146 869
+2%
|
161 809
+10%
|
166 445
+3%
|
163 734
-2%
|
154 666
-6%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(6 475)
|
(5 227)
|
(4 214)
|
(5 089)
|
(7 814)
|
(7 722)
|
(6 944)
|
(8 080)
|
(8 894)
|
(12 054)
|
(15 862)
|
(18 504)
|
(17 955)
|
(17 672)
|
(18 686)
|
(13 525)
|
(13 710)
|
(14 453)
|
(11 754)
|
(13 462)
|
(14 099)
|
(15 554)
|
(18 145)
|
(19 808)
|
(21 768)
|
(23 468)
|
(21 227)
|
(25 392)
|
(25 315)
|
(24 503)
|
(26 948)
|
(24 340)
|
(27 156)
|
(30 020)
|
(33 212)
|
(30 619)
|
(31 667)
|
(36 819)
|
(38 750)
|
(35 694)
|
(33 608)
|
|
| Income from Continuing Operations |
15 471
|
12 285
|
16 334
|
13 216
|
19 741
|
21 790
|
16 674
|
25 192
|
29 415
|
36 441
|
48 491
|
56 036
|
54 136
|
54 134
|
54 993
|
50 397
|
53 843
|
57 992
|
52 069
|
51 679
|
52 810
|
55 712
|
60 449
|
59 888
|
65 039
|
66 860
|
74 440
|
75 498
|
78 072
|
81 943
|
73 632
|
80 685
|
86 105
|
96 793
|
111 843
|
112 913
|
115 202
|
124 990
|
127 695
|
128 040
|
121 058
|
|
| Income to Minority Interest |
(210)
|
(188)
|
(167)
|
(240)
|
(220)
|
(223)
|
(224)
|
(213)
|
(210)
|
(217)
|
(221)
|
(243)
|
(248)
|
(250)
|
(234)
|
(113)
|
(99)
|
(73)
|
(92)
|
(140)
|
(176)
|
(202)
|
(214)
|
(184)
|
(167)
|
(121)
|
(75)
|
(72)
|
(69)
|
(77)
|
(74)
|
(166)
|
(184)
|
(226)
|
(289)
|
(190)
|
(138)
|
(115)
|
(84)
|
(62)
|
(104)
|
|
| Net Income (Common) |
15 261
N/A
|
12 095
-21%
|
16 169
+34%
|
12 976
-20%
|
19 521
+50%
|
21 568
+10%
|
16 449
-24%
|
24 979
+52%
|
29 206
+17%
|
36 225
+24%
|
48 271
+33%
|
55 793
+16%
|
53 888
-3%
|
53 884
0%
|
54 759
+2%
|
50 284
-8%
|
53 745
+7%
|
57 919
+8%
|
51 978
-10%
|
51 539
-1%
|
52 633
+2%
|
55 510
+5%
|
60 235
+9%
|
59 704
-1%
|
64 872
+9%
|
66 739
+3%
|
74 364
+11%
|
75 425
+1%
|
78 003
+3%
|
81 866
+5%
|
73 558
-10%
|
80 519
+9%
|
85 922
+7%
|
96 568
+12%
|
111 555
+16%
|
112 723
+1%
|
115 064
+2%
|
124 875
+9%
|
127 610
+2%
|
127 977
+0%
|
120 952
-5%
|
|
| EPS (Diluted) |
28.79
N/A
|
22.82
-21%
|
30.51
+34%
|
24.48
-20%
|
36.83
+50%
|
40.7
+11%
|
31.04
-24%
|
47.13
+52%
|
55.11
+17%
|
68.35
+24%
|
91.07
+33%
|
105.26
+16%
|
102.06
-3%
|
104.42
+2%
|
106.53
+2%
|
96.99
-9%
|
104.56
+8%
|
112.68
+8%
|
101.08
-10%
|
100.24
-1%
|
102.61
+2%
|
110.2
+7%
|
120.44
+9%
|
118.45
-2%
|
129.95
+10%
|
133.67
+3%
|
148.95
+11%
|
151.09
+1%
|
156.25
+3%
|
163.99
+5%
|
147.78
-10%
|
162.16
+10%
|
175.95
+9%
|
197.75
+12%
|
228.44
+16%
|
230.82
+1%
|
235.61
+2%
|
258.04
+10%
|
268.18
+4%
|
266.59
-1%
|
257.32
-3%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
